AIN/Sandipan Shringi
LightNews LightNews
nephrosage.bsky.social
AIN/Sandipan Shringi
@nephrosage.bsky.social
150 followers 770 following 77 posts
AnotherIndianNephrologist @Nephrosage
Posts Replies Media Videos
nephrosage.bsky.social
IDF Diabetes Atlas 11th edition 2025: global prevalence and projections for 2050
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
IDF Diabetes Atlas 11th edition 2025: global prevalence and projections for 2050
The prevalence and the burden of chronic kidney disease (CKD) are both rising steadily around the world [1]. Much of this rise can be attributed to a major
academic.oup.com
February 9, 2026 at 4:34 PM
nephrosage.bsky.social
The multiple autoantibodies in anti-GBM disease
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
The multiple autoantibodies in anti-GBM disease
Anti-glomerular basement membrane (GBM) disease has long been viewed as a prototypic, organ-specific autoimmune disease defined by autoreactivity to a sing
academic.oup.com
February 6, 2026 at 1:08 PM
nephrosage.bsky.social
Genome-wide donor–recipient non-HLA mismatch and graft loss
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Genome-wide donor–recipient non-HLA mismatch and graft loss
ABSTRACT. HLA-matching between donor (D) and recipient (R) is routinely performed in kidney allocation to optimize allograft survival but explains only a m
academic.oup.com
February 5, 2026 at 5:31 PM
nephrosage.bsky.social
Chronic lung diseases and kidney disease: pathophysiology and management
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Chronic lung diseases and kidney disease: pathophysiology and management
ABSTRACT. Acute kidney injury (AKI) is a critical complication in patients with chronic lung diseases (CLD), particularly during acute exacerbations. This
academic.oup.com
February 4, 2026 at 3:08 PM
nephrosage.bsky.social
Treatment of diabetes in patients with advanced chronic kidney disease or kidney failure
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Treatment of diabetes in patients with advanced chronic kidney disease or kidney failure
ABSTRACT. Chronic kidney disease (CKD) is common in both type 1 and type 2 diabetes and complicated glycemic control due to fluctuating insulin resistance
academic.oup.com
February 3, 2026 at 2:15 PM
nephrosage.bsky.social
Anti-glomerular basement membrane disease—treatment standard
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Anti-glomerular basement membrane disease—treatment standard
ABSTRACT. We review the current standards of treatment and discuss novel developments in the pathophysiology, diagnosis, outcome prediction and management
academic.oup.com
February 2, 2026 at 4:34 PM
nephrosage.bsky.social
Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease
ABSTRACTBackground. Anti-glomerular basement membrane (anti-GBM) disease is an autoimmune kidney disease in which autoantibodies are directed against GBM c
academic.oup.com
January 29, 2026 at 5:30 PM
nephrosage.bsky.social
Cardioprotection from intradialytic exercise: a randomized trial
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Cardioprotection from intradialytic exercise: a randomized trial
ABSTRACTBackground and hypothesis. Left ventricular (LV) regional wall motion abnormalities (RWMAs) related to transient ischemic events are well documente
academic.oup.com
January 28, 2026 at 3:08 PM
nephrosage.bsky.social
Genotype–phenotype correlations and clinical outcomes of genetic TRPC6 podocytopathies
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Genotype–phenotype correlations and clinical outcomes of genetic TRPC6 podocytopathies
ABSTRACTBackground and hypothesis. Podocytopathy associated with likely pathogenic/pathogenic variants of Transient receptor potential cation channel subfa
academic.oup.com
January 27, 2026 at 2:15 PM
nephrosage.bsky.social
Urinary rituximab loss and rate of treatment failure in membranous nephropathy
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Urinary rituximab loss and rate of treatment failure in membranous nephropathy
ABSTRACTBackground. Rituximab is a first-line treatment for primary membranous nephropathy, but approximately one-third of patients fail to respond. Among
academic.oup.com
January 26, 2026 at 4:34 PM
nephrosage.bsky.social
Association between exposure to air pollution and kidney function decline
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Association between exposure to air pollution and kidney function decline
ABSTRACTBackground and hypothesis. Chronic kidney disease is a major global health concern, with air pollution increasingly recognized as a key contributor
academic.oup.com
January 23, 2026 at 1:08 PM
nephrosage.bsky.social
Hemodialysis removes protective metabolites and disrupts mitochondrial function
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Hemodialysis removes protective metabolites and disrupts mitochondrial function
ABSTRACTBackground. Metabolic analyses offer valuable insights into the biochemical changes induced by hemodialysis, yet prior studies have focused on targ
academic.oup.com
January 22, 2026 at 5:31 PM
nephrosage.bsky.social
Association of urinary LIF levels with disease prognosis and treatment response to methylprednisolone in IgA nephropathy
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Association of urinary LIF levels with disease prognosis and treatment response to methylprednisolone in IgA nephropathy
ABSTRACTBackground. Leukemia inhibitory factor (LIF) has been implicated in the production of galactose-deficient immunoglobulin A1 (IgA1) and development
academic.oup.com
January 21, 2026 at 3:08 PM
nephrosage.bsky.social
Cost-effectiveness of protein restricted diets in advanced CKD
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Cost-effectiveness of protein restricted diets in advanced CKD
ABSTRACTBackground. The costs of dialysis are not sustainable everywhere, resulting in many avoidable deaths. Interventions that postpone the start of dial
academic.oup.com
January 20, 2026 at 2:15 PM
nephrosage.bsky.social
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial
ABSTRACTBackground. The CONFIDENCE (COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with CKD and type 2 diabetes using a UACR Endpoint)
academic.oup.com
January 19, 2026 at 4:34 PM
nephrosage.bsky.social
The unmet need of electrolyte supplements
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
The unmet need of electrolyte supplements
Electrolytes are essential for the management of various kidney pathologies, both hereditary and acquired, including rare diseases [1, 2]. In this specific
academic.oup.com
January 16, 2026 at 1:08 PM
nephrosage.bsky.social
Trends in Nephrology: From reducing proteinuria with steroids to curing glomerulonephritis
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Trends in Nephrology: From reducing proteinuria with steroids to curing glomerulonephritis
Glomerulonephritis (GN) is a subgroup of kidney disorders characterized by inflammation and injury at the glomerular filtration barrier manifesting as hype
academic.oup.com
January 15, 2026 at 5:30 PM
nephrosage.bsky.social
Long-term risks of adverse kidney outcomes after acute kidney injury: a systematic review and meta-analysis
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Long-term risks of adverse kidney outcomes after acute kidney injury: a systematic review and meta-analysis
ABSTRACTBackground. Acute kidney injury (AKI) is associated with increased risks of incidence or progression of chronic kidney disease (CKD), kidney failur
academic.oup.com
January 13, 2026 at 2:15 PM
nephrosage.bsky.social
A simple test of walking speed during transplant preassessment predicts positive cardiac investigations and mortality
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
A simple test of walking speed during transplant preassessment predicts positive cardiac investigations and mortality
ABSTRACTBackground. Prior to renal transplant listing, cardiovascular screening is performed to stratify the risk of cardiovascular disease (CVD). However,
academic.oup.com
January 12, 2026 at 4:34 PM
nephrosage.bsky.social
Foam sclerotherapy for symptomatic cysts in ADPKD, ADPLD and solitary cysts
More info : academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Foam sclerotherapy for symptomatic cysts in ADPKD, ADPLD and solitary cysts
ABSTRACTBackground. This medical center migrated from alcohol to sotradecol foam sclerotherapy (SFS) because of perceived improved efficacy in managing sym
academic.oup.com
January 9, 2026 at 1:08 PM
nephrosage.bsky.social
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease
ABSTRACTBackground. Type 2 diabetes (T2D) is the leading cause of chronic kidney disease (CKD) and kidney failure globally. Semaglutide, a glucagon-like pe
academic.oup.com
January 8, 2026 at 5:30 PM
nephrosage.bsky.social
Complement activation in secondary thrombotic microangiopathies
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Complement activation in secondary thrombotic microangiopathies
ABSTRACT. Secondary thrombotic microangiopathies (TMAs) represent a heterogeneous group of diseases associated with a high risk of kidney failure and death
academic.oup.com
January 7, 2026 at 3:08 PM
nephrosage.bsky.social
Self-reported non-adherence to immunosuppressive medication detected by the BAASIS predicts allograft rejections in kidney transplant recipients
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Self-reported non-adherence to immunosuppressive medication detected by the BAASIS predicts allograft rejections in kidney transplant recipients
ABSTRACTBackground. After kidney transplantation adherence to immunosuppressive medication is crucial for graft survival and its assessment requires valid
academic.oup.com
January 6, 2026 at 2:15 PM
nephrosage.bsky.social
The environmental and genetic architectures of ageing and CKD
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
The environmental and genetic architectures of ageing and CKD
Comment on: Argentieri MA, Amin N, Nevado-Holgado AJ, Sproviero W, Collister JA, Keestra SM, Kuilman MM, Ginos BNR, Ghanbari M, Doherty A, Hunter DJ, Alver
academic.oup.com
January 5, 2026 at 4:34 PM
nephrosage.bsky.social
High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia
ABSTRACTBackground and hypothesis. Major adverse cardiovascular events (MACE) are the main cause of mortality in hemodialysis (HD). Soluble CD40 ligand (sC
academic.oup.com
November 18, 2025 at 2:15 PM